Science Explorer Back to mapMap
Discussion
Hospital / health system · Krasnodar · Russia

Oncological Dispensary No. 2

onko-sochi.ruROR OpenAlex
Research works
51
▲ 43% vs 2018-21
Citations
101
2.0 per fractional work
Top-10% rate
2.5%
all institutions 10.0%
Open access
67%
world 40%
International
14%
world 18%
Oncological Dispensary No. 2

Not ranked overall: Oncological Dispensary No. 2 is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Oncological Dispensary No. 2 work in?

In all years, 78% of research at Oncological Dispensary No. 2 is in Health Sciences, 18% in Life Sciences. Its largest fields are Medicine (74%), Biochemistry, Genetics and Molecular Biology (12%), Immunology and Microbiology (3%). It does 2.9× the world's share of Health Sciences.

Health Sciences: 40 fractional works · 77.6% of its workMedicine: 38 fractional works · 74.0% of its workOncology: 8 fractional works · 14.7% of its workPulmonary and Respiratory Medicine: 6 fractional works · 12.2% of its workEpidemiology: 4 fractional works · 7.1% of its workSurgery: 4 fractional works · 7.1% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 3.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.4% of its workDermatology: 1 fractional works · 2.4% of its workReproductive Medicine: 1 fractional works · 2.3% of its workObstetrics and Gynecology: 1 fractional works · 2.2% of its workRheumatology: 1 fractional works · 2.0% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.0% of its workHepatology: 1 fractional works · 1.7% of its workHematology: 1 fractional works · 1.7% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 1.6% of its workPathology and Forensic Medicine: 1 fractional works · 1.5% of its workPsychiatry and Mental health: 1 fractional works · 1.5% of its workOphthalmology: 1 fractional works · 1.5% of its workPharmacology: 1 fractional works · 1.2% of its workGenetics: 1 fractional works · 1.1% of its workEmergency Medicine: 0 fractional works · 0.9% of its workOtorhinolaryngology: 0 fractional works · 0.8% of its workPhysiology: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workDentistry: 1 fractional works · 2.3% of its workOral Surgery: 1 fractional works · 2.0% of its workPeriodontics: 0 fractional works · 0.4% of its workHealth Professions: 1 fractional works · 1.0% of its workGeneral Health Professions: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 0.2% of its workNutrition and Dietetics: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 9 fractional works · 18.3% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 11.7% of its workCancer Research: 3 fractional works · 5.2% of its workMolecular Biology: 2 fractional works · 3.6% of its workGenetics: 1 fractional works · 1.3% of its workBiotechnology: 0 fractional works · 0.8% of its workBiophysics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workImmunology and Microbiology: 2 fractional works · 2.9% of its workImmunology: 1 fractional works · 2.6% of its workMicrobiology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 1.8% of its workBiological Psychiatry: 1 fractional works · 1.2% of its workNeurology: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.2% of its workToxicology: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workPlant Science: 0 fractional works · 0.6% of its workPhysical Sciences: 1 fractional works · 2.4% of its workEngineering: 0 fractional works · 1.0% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workCivil and Structural Engineering: 0 fractional works · 0.3% of its workChemistry: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workSpectroscopy: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.3% of its workStatistical and Nonlinear Physics: 0 fractional works · 0.3% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 1.8% of its workPsychology: 1 fractional works · 1.1% of its workSocial Psychology: 0 fractional works · 0.8% of its workClinical Psychology: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.5% of its workEducation: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.2% of its workArts and Humanities: 0 fractional works · 0.2% of its workALL ITS WORKOncologicalDispensary No. 251fractional works, all years
Life Sciences18%Physical Sciences2%Health Sciences78%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Medicine3874.0%
    2. Dentistry12.3%
    3. Health Professions11.0%
    4. Nursing00.2%
    5. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology611.7%
    2. Immunology and Microbiology22.9%
    3. Neuroscience11.8%
    4. Pharmacology, Toxicology and Pharmaceutics11.2%
    5. Agricultural and Biological Sciences00.6%
    1. Engineering01.0%
    2. Chemistry00.6%
    3. Computer Science00.3%
    4. Physics and Astronomy00.3%
    5. Environmental Science00.1%
    1. Psychology11.1%
    2. Social Sciences00.5%
    3. Arts and Humanities00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.37× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.10× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 4.01× its world share, 1 worksImmunology and Micro…Neuroscience: 0.22× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.25× its world share, 0 worksPharmacology, Toxico…Engineering: 0.18× its world share, 0 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.89× its world share, 0 worksHealth ProfessionsMedicine: 3.43× its world share, 12 worksMedicineNursing: 1.20× its world share, 0 worksNursingVeterinary: 1.08× its world share, 0 worksVeterinaryArts and Humanities: 0.15× its world share, 0 worksArts and HumanitiesPsychology: 1.01× its world share, 1 worksPsychologySocial Sciences: 0.10× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.0×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Immunology and Microbiology4.01×1 works
  2. Medicine3.43×12 works
  3. Biochemistry, Genetics and Molecular Biology3.10×3 works
  4. Pharmacology, Toxicology and Pharmaceutics1.25×0 works
  5. Nursing1.20×0 works
  6. Veterinary1.08×0 works
  7. Psychology1.01×1 works
  8. Health Professions0.89×0 works
  9. Agricultural and Biological Sciences0.37×0 works
  10. Neuroscience0.22×0 works
  11. Engineering0.18×0 works
  12. Arts and Humanities0.15×0 works
  13. Social Sciences0.10×0 works
  14. Environmental Science0.07×0 works

What are the most cited papers from Oncological Dispensary No. 2?

The most cited paper from Oncological Dispensary No. 2 is "A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer" (Rebecca Sophie Kristeleit, Ірина Давиденко, Vadim Shirinkin et al., 2017), with 102 citations. Next come "Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy" (81) and "Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma" (45).

Most cited papers
#PaperReleasedCitations
1 A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer Rebecca Sophie Kristeleit, Ірина Давиденко, Vadim Shirinkin et al. · Gynecologic Oncology Open access 8 Jul 2017 102
2 Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy Kimberly Blackwell, Vladimir Semiglazov, Dmitriy Krasnozhon et al. · Annals of Oncology Open access 30 Jun 2015 81
3 Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma DAVID J. PROPPER, Ірина Давиденко, John A. Bridgewater et al. · Annals of Oncology Open access 15 May 2014 45
4 Different types of tumor vessels in breast cancer: morphology and clinical value M. A. Senchukova, Natalia V. Nikitenko, Olesia N. Tomchuk et al. · SpringerPlus Open access 17 Sep 2015 44
5 Randomized, Double-Blind Study Comparing Proposed Biosimilar La-Ep2006 with Reference Pegfilgrastim in Breast Cancer Nadia Harbeck, Oleg Nikolaevich Lipatov, Мона Александровна Фролова et al. · Future Oncology Open access 29 Mar 2016 38
All 75 most cited papers, with filters and sorting

Which keywords describe research at Oncological Dispensary No. 2?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Breast Cancer, Survival Analysis, Immunotherapy, Metastatic Breast Cancer, Neoadjuvant Therapy and Clinical Trials.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy5▲ 14×14 topics
  2. Clinical Practice Guidelines5▲ 16×7 topics
  3. Epidemiology4▲ 2.2×20 topics
  4. Breast Cancer4▲ 30×6 topics
  5. Survival Analysis4▲ 25×4 topics
  6. Immunotherapy3▲ 10×10 topics
  7. Metastatic Breast Cancer3▲ 101×2 topics
  8. Neoadjuvant Therapy3▲ 30×5 topics
  9. Clinical Trials3▲ 9.8×5 topics
  10. Metastasis3▲ 16×7 topics
  11. CDK4/6 Inhibitors3▲ 320×1 topic
  12. Palbociclib3▲ 320×1 topic
  13. Biomarkers2▲ 7.7×7 topics
  14. Radiotherapy2▲ 12×4 topics
  15. Risk Factors2▲ 4.4×6 topics
  16. Cancer2▲ 3.0×14 topics
  17. Quality of Life2▲ 3.2×9 topics
  18. Prognostic Factors2▲ 8.7×9 topics
  19. Sentinel Lymph Node Biopsy2▲ 55×2 topics
  20. Prevention2▲ 9.0×2 topics
  21. Gene Expression2▲ 5.4×4 topics
  22. Laparoscopic Surgery2▲ 30×2 topics
  23. Prognostic Markers2▲ 35×2 topics
  24. Radiation Therapy2▲ 22×3 topics
  25. Tumor Microenvironment2▲ 9.2×5 topics
  26. Tumor Markers2▲ 43×2 topics
  27. Genetic Mutations2▲ 5.8×5 topics
  28. Melanoma2▲ 58×2 topics
  29. Photodynamic Therapy2▲ 18×3 topics
  30. Robotic Surgery2▲ 21×2 topics
  31. Urothelial Carcinoma2▲ 67×2 topics
  32. Adjuvant Chemotherapy1▲ 37×2 topics
  33. Breast Tumours1▲ 54×1 topic
  34. Molecular Subtypes1▲ 32×2 topics
  35. Preoperative Chemoradiotherapy1▲ 38×2 topics
  36. Treatment Response1▲ 54×1 topic
  37. Cardiovascular Diseases1▲ 22×1 topic
  38. Mortality Trends1▲ 99×1 topic
  39. Rectal Cancer1▲ 72×1 topic
  40. Total Mesorectal Excision1▲ 72×1 topic

Which research topics does Oncological Dispensary No. 2 publish most on?

By volume in 2022-now: Advanced Breast Cancer Therapies, Endometrial and Cervical Cancer Treatments, Breast Cancer Treatment Studies and Cancer Immunotherapy and Biomarkers.

Advanced Breast Cancer T…2Advanced Breast Cancer Therapies: 2 fractional worksEndometrial and Cervical Cancer Treatments: 1 fractional worksBreast Cancer Treatment Studies: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksCancer-related molecular…1Cancer-related molecular mechanisms research: 1 fractional worksChemotherapy-induced cardiotoxicity and mitigation: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional worksCutaneous Melanoma Detection and Management: 0 fractional works
Pulmonary and Respiratory MedicineObstetrics and GynecologyCancer ResearchOncology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  2. 2 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
  3. 3 Breast Cancer Treatment Studies Cancer Research 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 1 works
  6. 6 HER2/EGFR in Cancer Research Oncology 1 works
  7. 7 Cancer-related molecular mechanisms research Cancer Research 1 works
  8. 8 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 0 works
  9. 9 Cancer Treatment and Pharmacology Oncology 0 works
  10. 10 Cutaneous Melanoma Detection and Management Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.7%not open33.3%

World: 40% of research is openly available.

with international co-authors14.0%domestic only86.0%

World: 18% is written across borders.

How has Oncological Dispensary No. 2's research output changed?

Output in 2022-2025 was 43% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Oncological Dispensary No. 2 as a percentage of every work published that year, 0.000034% in 2024.

still counting0.00010%0.00020%Oncological Dispensary No. 20.000064% in 202519801990200020102020

Fractional works of Oncological Dispensary No. 2 over all fractional works that year. How the balance of science has shifted.

Other research institutions in Krasnodar

All research institutions in Krasnodar

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Oncological Dispensary No. 2. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.